PIK3CA and neoplasm: According to the previous reports, over 80% of somatic, activating PIK3CA mutations in solid cancers and benign overgrowth disorders cluster at three residues, two glutamic acids (E) residues at codons 542 and 545, and a histidine (H) residue at codon 1047.